Akihiko Kuniyasu Selected Research

Glycoproteins (Glycoprotein)

11/2016

The novel monoclonal antibody 9F5 reveals expression of a fragment of GPNMB/osteoactivin processed by furin-like protease(s) in a subpopulation of microglia in neonatal rat brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihiko Kuniyasu Research Topics

Disease

6	Neoplasms (Cancer) 11/2021 - 06/2007
4	Insulin Resistance 03/2011 - 02/2003
3	Leukemia 07/2015 - 04/2008
3	Lymphoma (Lymphomas) 07/2015 - 04/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2011 - 12/2004
2	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 07/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 07/2009
2	Atherosclerosis 03/2011 - 01/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2021
1	Melanoma (Melanoma, Malignant) 11/2016
1	Osteosarcoma (Osteogenic Sarcoma) 07/2015
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Memory Disorders (Memory Loss) 01/2014
1	Neuroinflammatory Diseases 01/2014
1	Chronic Renal Insufficiency 09/2011
1	Hematologic Neoplasms (Hematological Malignancy) 01/2011
1	Genetic Translocation (Chromosomal Translocation) 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2008
1	Breast Neoplasms (Breast Cancer) 04/2008
1	Ischemia 06/2005
1	Reperfusion Injury 06/2005
1	Obesity 02/2003
1	Diabetes Complications 02/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
4	LigandsIBA 07/2015 - 06/2005
4	Peptides (Polypeptides)IBA 01/2014 - 06/2007
3	Pharmaceutical PreparationsIBA 10/2021 - 04/2008
2	Nuclear Pore Complex Proteins (Nucleoporins)IBA 11/2021 - 05/2018
2	PeptidomimeticsIBA 07/2015 - 04/2008
2	Amyloid (Amyloid Fibrils)IBA 01/2014 - 07/2009
2	tamibaroteneIBA 01/2014 - 07/2009
2	oxidized low density lipoproteinIBA 03/2011 - 12/2004
2	Peptide LibraryIBA 01/2011 - 04/2008
2	Imatinib Mesylate (Gleevec)FDA Link 01/2010 - 04/2008
2	LeptinIBA 06/2005 - 12/2004
1	AcidsIBA 10/2021
1	hydroxypropyl methacrylateIBA 10/2021
1	N-(2-hydroxypropyl)methacrylamideIBA 10/2021
1	BradykininIBA 10/2021
1	liposomal doxorubicin (Doxil)FDA Link 10/2021
1	1-dodecylpyridoxal (PLD)IBA 10/2021
1	Glycoproteins (Glycoprotein)IBA 11/2016
1	IgA receptor (protein B)IBA 11/2016
1	AntigensIBA 11/2016
1	Interleukin-11 Receptors (Interleukin 11 Receptor)IBA 07/2015
1	bone metastasis-targeting peptidomimetic-11IBA 07/2015
1	HX 630IBA 01/2014
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2014
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2014
1	AntioxidantsIBA 09/2011
1	LipidsIBA 03/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2011
1	Plasminogen Activator Inhibitor 1IBA 03/2011
1	phenylalanylphenylalanineIBA 01/2011
1	leucylarginineIBA 01/2011
1	Neuropilin-1IBA 01/2011
1	bcr-abl Fusion ProteinsIBA 01/2010
1	RetinoidsIBA 07/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2008
1	Trans-Activators (Trans-Acting Factor)IBA 04/2008
1	Organic Cation Transporter 1IBA 04/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2008
1	Adenosine Triphosphate (ATP)IBA 06/2005
1	AprindineIBA 06/2005
1	Advanced Glycation End ProductsIBA 02/2003
1	CholesterolIBA 01/2003

Therapy/Procedure

2	Therapeutics 01/2011 - 04/2008
1	Oral Administration 07/2009